Increase/Decrease in Cash: The total change in cash for the company over the given period.
PURE Bioscience (PURE) had Increase/Decrease in Cash of $-0.01M for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
$0.76M |
|
$-0.33M |
|
$0.30M |
|
$0.47M |
|
$1.10M |
|
$-0.34M |
|
$0.00M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.34M |
|
$-0.34M |
|
111.86M |
|
111.86M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$1.05M |
|
$0.01M |
|
$0.01M |
|
$1.06M |
|
$0.94M |
|
$5.24M |
|
$5.24M |
|
$6.17M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
111.89M |
|
| Cash Flow Statement Financials | |
$-2.02M |
|
-- |
|
$2.00M |
|
$0.42M |
|
$0.41M |
|
|
Increase/Decrease in Cash |
$-0.01M |
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
43.63 |
|
-1.02 |
|
61.26% |
|
-43.98% |
|
-43.98% |
|
-- |
|
-43.46% |
|
-43.46% |
|
$-2.02M |
|
-- |
|
-- |
|
-- |
|
0.72 |
|
2.10 |
|
1.61 |
|
55.84 |
|
6.49% |
|
6.49% |
|
-31.38% |
|
-276.67% |
|
$-0.05 |
|
$-0.02 |
|
$-0.02 |
|